EMBC
NASDAQ · Health Care
Embecta Corp
$3.11
+0.02 (+0.65%)
Analyst Consensus
Strong Sell
9
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,977.5% upside
Low Target
$42.86
Average Target
$64.61
High Target
$95.95
Current Price
$3.11
Current
$3.11
$3.11
Target
$64.61
$64.61
$42.86
$64.61 avg
$95.95
Scenario Analysis
Bear Case
$42.86
1,278.1%
Low target
Base Case
$64.61
+1,977.5%
Avg target
Bull Case
$95.95
+2,985.2%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$15.55
-80.0% from high
52-Week Low
$2.77
+12.3% from low
Target vs 52W High
$64.61
+315.5% vs high
Peer Consensus — Health Care
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| UNH | Strong Buy | 34 | 76% | $293.85 | -27.6% |
| ABT | Buy | 34 | 71% | $123.47 | +36.4% |
| ISRG | Buy | 40 | 70% | $219.77 | -45.3% |
| CVS | Strong Buy | 33 | 82% | $162.09 | +59.1% |
| SYK | Strong Buy | 35 | 77% | $338.36 | +7.9% |
| MDT | Buy | 37 | 57% | $192.46 | +140.2% |
| MCK | Strong Buy | 23 | 87% | $307.39 | -59.9% |
| ELV | Buy | 29 | 59% | $135.77 | -64.6% |